T-Cell Large Granular Lymphocyte Population Involving Chimeric Antigen Receptor-Modified T (CAR T) Cells in Patients with Cytopenia after CD19-Targeted CAR T-Cell Therapy: Case Series
Aya Albittar(University of Washington), Alexandre V. Hirayama(University of Washington), Erik L. Kimble(University of Washington), David G. Maloney(Fred Hutch Cancer Center), Delaney R. Kirchmeier(Fred Hutch Cancer Center), Aiko Torkelson(Fred Hutch Cancer Center), Andrew J. Portuguese(University of Washington), Aude G. Chapuis(University of Washington), Brian G. Till(University of Washington), Mazyar Shadman(University of Washington), Filippo Milano(Fred Hutch Cancer Center), Hans‐Peter Kiem(Fred Hutch Cancer Center), Folashade Otegbeye(University Hospitals of Cleveland), Cecilia C.S. Yeung(University of Washington), Ryan D. Cassaday(University of Washington), Emily C. Liang(Fred Hutch Cancer Center), Cameron J. Turtle(The University of Sydney), Abigail Chutnik(Fred Hutch Cancer Center), Alireza Torabi(University of Washington), Jennifer J. Huang(Stanford Medicine), Jordan Gauthier(Seattle Cancer Care Alliance)
Cited by 6
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
|Blood|2017|1.1k